Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration

Endoplasmic reticulum stress (ERS) is a kind of cell response for coping with hypoxia and other stresses. Pieces of evidence show that continuous stress can promote the occurrence, development, and drug resistance of tumors through the unfolded protein response. Therefore, the abnormal ac-tivation o...

Full description

Bibliographic Details
Main Authors: Bowen Qing, Song Wang, Yingan Du, Can Liu, Wei Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1273987/full
_version_ 1797681796559667200
author Bowen Qing
Song Wang
Yingan Du
Can Liu
Wei Li
author_facet Bowen Qing
Song Wang
Yingan Du
Can Liu
Wei Li
author_sort Bowen Qing
collection DOAJ
description Endoplasmic reticulum stress (ERS) is a kind of cell response for coping with hypoxia and other stresses. Pieces of evidence show that continuous stress can promote the occurrence, development, and drug resistance of tumors through the unfolded protein response. Therefore, the abnormal ac-tivation of ERS and its downstream signaling pathways not only can regulate tumor growth and metastasis but also profoundly affect the efficacy of antitumor therapy. Therefore, revealing the molecular mechanism of ERS may be expected to solve the problem of tumor multidrug resistance (MDR) and become a novel strategy for the treatment of refractory and recurrent tumors. This re-view summarized the mechanism of ERS and tumor MDR, reviewed the relationship between ERS and tumor MDR, introduced the research status of tumor tissue and ERS, and previewed the prospect of targeting ERS to improve the therapeutic effect of tumor MDR. This article aims to provide researchers and clinicians with new ideas and inspiration for basic antitumor treatment.
first_indexed 2024-03-11T23:50:13Z
format Article
id doaj.art-6ba7f93607954186b9c0865a32279bda
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-11T23:50:13Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-6ba7f93607954186b9c0865a32279bda2023-09-19T07:36:11ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-09-011410.3389/fphar.2023.12739871273987Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustrationBowen Qing0Song Wang1Yingan Du2Can Liu3Wei Li4First Affiliated Hospital of Hunan Normal University, Department of Hematology, Hunan Provincial People’s Hospital, Changsha, ChinaDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, ChinaFirst Affiliated Hospital of Hunan Normal University, Department of Hematology, Hunan Provincial People’s Hospital, Changsha, ChinaFirst Affiliated Hospital of Hunan Normal University, Department of Hematology, Hunan Provincial People’s Hospital, Changsha, ChinaFirst Affiliated Hospital of Hunan Normal University, Department of Hematology, Hunan Provincial People’s Hospital, Changsha, ChinaEndoplasmic reticulum stress (ERS) is a kind of cell response for coping with hypoxia and other stresses. Pieces of evidence show that continuous stress can promote the occurrence, development, and drug resistance of tumors through the unfolded protein response. Therefore, the abnormal ac-tivation of ERS and its downstream signaling pathways not only can regulate tumor growth and metastasis but also profoundly affect the efficacy of antitumor therapy. Therefore, revealing the molecular mechanism of ERS may be expected to solve the problem of tumor multidrug resistance (MDR) and become a novel strategy for the treatment of refractory and recurrent tumors. This re-view summarized the mechanism of ERS and tumor MDR, reviewed the relationship between ERS and tumor MDR, introduced the research status of tumor tissue and ERS, and previewed the prospect of targeting ERS to improve the therapeutic effect of tumor MDR. This article aims to provide researchers and clinicians with new ideas and inspiration for basic antitumor treatment.https://www.frontiersin.org/articles/10.3389/fphar.2023.1273987/fullendoplasmic reticulum stressunfolded protein responsemultidrug resistanceapoptosismolecular mechanism
spellingShingle Bowen Qing
Song Wang
Yingan Du
Can Liu
Wei Li
Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
Frontiers in Pharmacology
endoplasmic reticulum stress
unfolded protein response
multidrug resistance
apoptosis
molecular mechanism
title Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
title_full Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
title_fullStr Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
title_full_unstemmed Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
title_short Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
title_sort crosstalk between endoplasmic reticulum stress and multidrug resistant cancers hope or frustration
topic endoplasmic reticulum stress
unfolded protein response
multidrug resistance
apoptosis
molecular mechanism
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1273987/full
work_keys_str_mv AT bowenqing crosstalkbetweenendoplasmicreticulumstressandmultidrugresistantcancershopeorfrustration
AT songwang crosstalkbetweenendoplasmicreticulumstressandmultidrugresistantcancershopeorfrustration
AT yingandu crosstalkbetweenendoplasmicreticulumstressandmultidrugresistantcancershopeorfrustration
AT canliu crosstalkbetweenendoplasmicreticulumstressandmultidrugresistantcancershopeorfrustration
AT weili crosstalkbetweenendoplasmicreticulumstressandmultidrugresistantcancershopeorfrustration